DE69019072D1 - Zusammensetzungen und methode zur behandlung oder prophylaxe von sepsis oder septischem schock. - Google Patents

Zusammensetzungen und methode zur behandlung oder prophylaxe von sepsis oder septischem schock.

Info

Publication number
DE69019072D1
DE69019072D1 DE69019072T DE69019072T DE69019072D1 DE 69019072 D1 DE69019072 D1 DE 69019072D1 DE 69019072 T DE69019072 T DE 69019072T DE 69019072 T DE69019072 T DE 69019072T DE 69019072 D1 DE69019072 D1 DE 69019072D1
Authority
DE
Germany
Prior art keywords
sepsis
prophylaxis
compositions
treating
septic shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69019072T
Other languages
English (en)
Other versions
DE69019072T2 (de
Inventor
Joyce Lawrence
Michael Griffith
Melaine Alpern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23160797&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69019072(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of DE69019072D1 publication Critical patent/DE69019072D1/de
Publication of DE69019072T2 publication Critical patent/DE69019072T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69019072T 1989-01-24 1990-01-17 Zusammensetzungen und methode zur behandlung oder prophylaxe von sepsis oder septischem schock. Expired - Fee Related DE69019072T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/300,836 US5093117A (en) 1989-01-24 1989-01-24 Compositions and method for the treatment or prophylaxis of sepsis or septic shock
PCT/US1990/000215 WO1990008556A1 (en) 1989-01-24 1990-01-17 Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Publications (2)

Publication Number Publication Date
DE69019072D1 true DE69019072D1 (de) 1995-06-08
DE69019072T2 DE69019072T2 (de) 1995-11-30

Family

ID=23160797

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019072T Expired - Fee Related DE69019072T2 (de) 1989-01-24 1990-01-17 Zusammensetzungen und methode zur behandlung oder prophylaxe von sepsis oder septischem schock.

Country Status (8)

Country Link
US (1) US5093117A (de)
EP (1) EP0406398B1 (de)
JP (1) JP3038006B2 (de)
CA (1) CA1339990C (de)
DE (1) DE69019072T2 (de)
DK (1) DK0406398T3 (de)
ES (1) ES2074563T3 (de)
WO (1) WO1990008556A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402260B (de) * 1990-08-16 1997-03-25 Immuno Ag Protein c-hältige pharmazeutische präparation
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
AU4784693A (en) 1992-07-24 1994-02-14 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
US7060484B1 (en) 1993-11-12 2006-06-13 Gilead Sciences, Inc. Polypeptides and coagulation therapy
EP0728210B1 (de) * 1993-11-12 2005-04-13 Gilead Sciences, Inc. Thrombin mutanten
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US20060127387A1 (en) * 1997-04-22 2006-06-15 Zikria Bashir A Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions
US6630137B1 (en) * 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
WO1998048818A1 (en) * 1997-04-28 1998-11-05 Eli Lilly And Company Activated protein c formulations
DE19726248C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme und Rutosid zur Behandlung von septischem Schock
US6953568B1 (en) 1998-08-25 2005-10-11 Oklahoma Medical Research Foundation Targeting of molecules to large vessel endothelium using EPCR
BR9914735A (pt) * 1998-10-22 2001-07-03 Lilly Co Eli Processo para tratamento de sépsia
JP2002542148A (ja) * 1998-12-21 2002-12-10 イーライ・リリー・アンド・カンパニー 敗血症の処置のための組み合わせ療法
US6679870B1 (en) 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6685694B2 (en) 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
WO2001089558A2 (en) 2000-05-24 2001-11-29 Eli Lilly And Company Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
US20030190314A1 (en) * 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
MXPA03006818A (es) * 2001-01-30 2004-10-15 Lauridsen Group Inc Metodos y composiciones para modular el sistema inmune de animales.
MXPA03006819A (es) * 2001-01-30 2004-10-15 Lauridsen Group Inc Metodos y composiciones para eltratamiento de transtornos de disfuncion inmune.
WO2003007686A2 (en) * 2001-07-19 2003-01-30 Dmi Biosciences, Inc. Use of copper chelators to inhibit the inactivation of protein c
JP2005528351A (ja) * 2002-03-08 2005-09-22 イーライ・リリー・アンド・カンパニー 活性化プロテインｃ製剤
US8329169B2 (en) 2003-05-15 2012-12-11 Genentech, Inc. Methods and compositions for the prevention and treatment of sepsis
EP1819731A4 (de) * 2004-12-08 2013-02-13 Immunomedics Inc Verfahren und zusammensetzung zur immuntherapie und für den nachweis von entzündungs- und dysregulatorischen immunerkrankungen, infektionserkrankungen, pathologischer angiogenese und krebs
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
ITFI20070063A1 (it) * 2007-03-15 2008-09-16 Kedrion Spa Concentrato di proteina c contenente proteina s, sua preparazione ed uso.
WO2014005183A1 (en) 2012-07-04 2014-01-09 The University Of Sydney Treatment of inflammatory skin disorders
CN106573040B (zh) 2014-04-16 2021-07-06 Zz生物技术有限责任公司 治疗异常皮肤瘢痕形成

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
GB8319538D0 (en) * 1983-07-20 1983-08-24 Beecham Group Plc Compounds
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S

Also Published As

Publication number Publication date
CA1339990C (en) 1998-08-11
EP0406398A4 (en) 1991-07-03
DE69019072T2 (de) 1995-11-30
ES2074563T3 (es) 1995-09-16
JP3038006B2 (ja) 2000-05-08
JPH03503536A (ja) 1991-08-08
WO1990008556A1 (en) 1990-08-09
DK0406398T3 (da) 1995-07-17
EP0406398A1 (de) 1991-01-09
US5093117A (en) 1992-03-03
EP0406398B1 (de) 1995-05-03

Similar Documents

Publication Publication Date Title
DE69019072D1 (de) Zusammensetzungen und methode zur behandlung oder prophylaxe von sepsis oder septischem schock.
DE68912781D1 (de) Verfahren und zusammensetzungen für die behandlung und zur verhütung von septischen schock.
DE69421912D1 (de) Methode zur behandlung von wasser
DE3581642D1 (de) Antimikrobielle antistatische siloxanzusammensetzungen und verfahren zur behandlung von materialien.
DE3585160D1 (de) Verfahren zur behandlung von schmelzverarbeitbaren copolymeren von tetrafluoraethylen und perfluoralkylvinylaether.
DE3856398T2 (de) Verfahren zur Behandlung von Gleitkörpern
DE69033509D1 (de) Laserverfahren zur Behandlung von Mikrokapseln oder Teilchen
DE69222735D1 (de) Zusammensetzung und Verfahren zur Behandlung von Kühlwasser
DE69018457T2 (de) Gegenstände zur behandlung von periodontitis und knochendefekten.
DE69415526D1 (de) Methode zur behandlung von wasserbehandlungsschlamm
DE69425131D1 (de) Verwendung von clavulansäure und einem antibiotikum zur behandlung von infektionen
DE69000620D1 (de) Verfahren zur anlage zur biologischen abwasserreinigung, speziell zur nitrifikation und/oder denitrifikation von stickstoffhaltigem abwasser.
DE3581703D1 (de) Verfahren und vorrichtung zur biologischen behandlung von wasser, insbesondere zur denitrifikation von rohwasser zur trinkwasseraufbereitung.
DE69214795T2 (de) Verfahren und Anlage zur Aufbereitung von organischem Schlamm, insbesondere Klärschlamm
DE69525434D1 (de) Verfahren zur keimungshemmenden Behandlung von Knollen oder Zwiebeln
NO883541D0 (no) Fremgangsmaate og anlegg for behandling av raaolje og slam.
PT80152B (de) Methode zur behandlung des glaukoms vok
DE19724049B4 (de) Verfahren und Anlage zur Behandlung von Klärschlämmen oder Schlämmen ähnlicher Konsistenz
DE3580431D1 (de) Prophylaxeverfahren oder behandlung von atherosklerose.
ATA96097A (de) Verwendung von queller zur behandlung oder prophylaxe von jodmangelerscheinungen
DE3881377T2 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE68906651T2 (de) Zusammensetzung und verfahren zur behandlung von metalloberflaechen.
DE3583337D1 (de) Zusammensetzung zur behandlung von haemorroiden.
ATE45561T1 (de) Verfahren und anlage zur indirekten schlammtrocknung insbesondere von abwaesserschlaemmen.
ATE100718T1 (de) Verfahren und zusammensetzungen fuer die behandlung und zur verhuetung von septischen schock.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee